AIMS/HYPOTHESIS: The relationship between BP and microalbuminuria in young people with type 1 diabetes is not completely clear. As microalbuminuria is preceded by a gradual rise in albumin excretion within the normal range, we hypothesised that ambulatory BP (ABP) may be closely related to albumin excretion and progression to microalbuminuria. METHODS: ABP monitoring (ABPM) was performed in 509 young people with type 1 diabetes (age median [range]: 15.7 [10.7-22.6] years) followed with annual assessments of three early morning urinary albumin:creatinine ratios (ACRs) and HbA(1c). Systolic BP (SBP) and diastolic BP (DBP) and the nocturnal fall in BP were analysed in relation to ACR. RESULTS: All ABPM variables were significantly related to baseline log(10) ACR (p < 0.001). After the ABPM evaluation, 287 patients were followed for a median of 2.2 (1.0-5.5) years. ABP at baseline was independently related to mean ACR during follow-up. Nineteen initially normoalbuminuric patients developed microalbuminuria after 2.0 (0.2-4.0) years and their baseline daytime DBP was higher than in normoalbuminuric patients (p < 0.001). After adjusting for baseline ACR and HbA(1c), there was an 11% increased risk of microalbuminuria for each 1 mmHg increase in daytime DBP. Forty-eight per cent of patients were non-dippers for SBP and 60% for DBP; however, ACR was not different between dippers and non-dippers and there were no differences in the nocturnal fall in BP between normoalbuminuric and future microalbuminuric patients. CONCLUSIONS/ INTERPRETATION: In this cohort of young people with type 1 diabetes, ABP was significantly related to ACR, and daytime DBP was independently associated with progression to microalbuminuria. Increasing albumin excretion, even in the normal range, may be associated with parallel rises in BP.
AIMS/HYPOTHESIS: The relationship between BP and microalbuminuria in young people with type 1 diabetes is not completely clear. As microalbuminuria is preceded by a gradual rise in albumin excretion within the normal range, we hypothesised that ambulatory BP (ABP) may be closely related to albumin excretion and progression to microalbuminuria. METHODS: ABP monitoring (ABPM) was performed in 509 young people with type 1 diabetes (age median [range]: 15.7 [10.7-22.6] years) followed with annual assessments of three early morning urinary albumin:creatinine ratios (ACRs) and HbA(1c). Systolic BP (SBP) and diastolic BP (DBP) and the nocturnal fall in BP were analysed in relation to ACR. RESULTS: All ABPM variables were significantly related to baseline log(10) ACR (p < 0.001). After the ABPM evaluation, 287 patients were followed for a median of 2.2 (1.0-5.5) years. ABP at baseline was independently related to mean ACR during follow-up. Nineteen initially normoalbuminuric patients developed microalbuminuria after 2.0 (0.2-4.0) years and their baseline daytime DBP was higher than in normoalbuminuric patients (p < 0.001). After adjusting for baseline ACR and HbA(1c), there was an 11% increased risk of microalbuminuria for each 1 mmHg increase in daytime DBP. Forty-eight per cent of patients were non-dippers for SBP and 60% for DBP; however, ACR was not different between dippers and non-dippers and there were no differences in the nocturnal fall in BP between normoalbuminuric and future microalbuminuric patients. CONCLUSIONS/ INTERPRETATION: In this cohort of young people with type 1 diabetes, ABP was significantly related to ACR, and daytime DBP was independently associated with progression to microalbuminuria. Increasing albumin excretion, even in the normal range, may be associated with parallel rises in BP.
Authors: Xiaoling Wang; Joseph C Poole; Frank A Treiber; Gregory A Harshfield; Coral D Hanevold; Harold Snieder Journal: Circulation Date: 2006-11-27 Impact factor: 29.690
Authors: P H Gallego; A J Gilbey; M T Grant; M K Bulsara; G C Byme; T W Jones; F L Frazer Journal: J Pediatr Endocrinol Metab Date: 2005-09 Impact factor: 1.634
Authors: Rachel M Williams; Kevin Yuen; Debbie White; Beth Mallard; R Neil Dalton; Carlo L Acerini; David B Dunger Journal: Clin Endocrinol (Oxf) Date: 2006-10 Impact factor: 3.478
Authors: Alessandra Rollo; S Salardi; A Ciavarella; G Forlani; M Scipione; G Maltoni; C Balsamo; A L Martini; S Zucchini Journal: J Endocrinol Invest Date: 2014-05-23 Impact factor: 4.256
Authors: Niina Sandholm; Carol Forsblom; Ville-Petteri Mäkinen; Amy Jayne McKnight; Anne-May Osterholm; Bing He; Valma Harjutsalo; Raija Lithovius; Daniel Gordin; Maija Parkkonen; Markku Saraheimo; Lena M Thorn; Nina Tolonen; Johan Wadén; Jaakko Tuomilehto; Maria Lajer; Emma Ahlqvist; Anna Möllsten; M Loredana Marcovecchio; Jason Cooper; David Dunger; Andrew D Paterson; Gianpaolo Zerbini; Leif Groop; Lise Tarnow; Alexander P Maxwell; Karl Tryggvason; Per-Henrik Groop Journal: Diabetologia Date: 2014-03-05 Impact factor: 10.122
Authors: M Loredana Marcovecchio; Paivi H Tossavainen; Carlo L Acerini; Timothy G Barrett; Julie Edge; Andrew Neil; Julian Shield; Barry Widmer; R Neil Dalton; David B Dunger Journal: Diabetes Care Date: 2009-11-16 Impact factor: 19.112